ABSTRACT. Cytochrome P450 2D (CYP2D) is one of the major metabolizing enzymes for drugs in humans and other mammals. Although domestic cats (Felis catus) are the most common companion animal in many countries, the properties of their drug-metabolizing system are largely unknown. We determined the complete cDNA sequence of the CYP2D open reading frame (1,500 bp) with both 5'-and 3'-untranslated regions in domestic cats. Feline CYP2D consists of 500 deduced amino acids and shows high homology with CYP2Ds of primates and rodents, particularly with the canine CYP2D homologue, and was designated as CYP2D6 based on its genomic structure. CYP2D6 transcripts were expressed predominantly in the liver and to a much lesser in the testis, suggesting the role of xenobiotic metabolism in the liver.
Cytochrome P450 (CYP) monooxygenase is the most important enzyme for metabolism of chemicals to polar substances for excretion and to active intermediates causing toxicological responses in some cases. Among the numerous members of the CYP superfamily, the CYP1A, 2B, 2C, 2D, 2E and 3A subfamilies are particularly important for drug metabolism. CYP2D is constitutively expressed in the liver and plays a major role in the oxidation of a wide range of substrates including -adrenoceptor blockers, Class I antiarrhythmics, tricyclic antidepressants and others in humans [15] . Domestic cats (Felis catus) are the most common companion animal in Japan and many western countries. H o w e v e r , k n o w l e d g e o f C Y P s i n v o l v e d i n t h e biotransformation of drugs and other xenobiotics in cats is mostly lacking. It is well known that cats are very sensitive to chemicals, and this is partly because of a deficiency of glucuronidation [2] . Among the few reports on feline CYPs, Shah et al. [8] characterized CYP1A-, 2C-, 2D-and 3A-dependent enzymatic activities in domestic cats using liver microsomes. Feline CYP2A and CYP2E have been studied with typical human CYP substrates to compare their metabolic activity with CYPs from other mammals [1, 6] . Only the molecular and enzymatic properties of CYP1A1, CYP1A2 and CYP2E have been studied in domestic cats [9, 10] , and there is no other information available, even in other felids.
In the present study, we determined the complete cDNA sequence of the open reading frame of feline CYP2D with the 5'-and 3'-ends and deduced amino acid sequences with the expression in various tissues in domestic cats.
Mongrel cats of both sexes (short-haired type; 3 male and 3 female), originally bred at laboratory animal facilities of Sapporo Medical University, received humane care under the guidelines of Sapporo Medical University for laboratory animals, and the experimental protocol was approved by the Committee for Animal Experiments at Rakuno Gakuen University. They were allowed access to food and drinking water ad libitum and were maintained at 25 ± 1°C under a standard 12-hr light-dark cycle. The livers were removed from cats anesthetized by intravenous administration of pentobarbital sodium (50 mg/kg body weight). Total RNA was extracted from the livers of the domestic cats using a conventional acid guanidine-phenol-chloroform method (Trizol; Invitrogen, Carlsbad, CA, U.S.A.) [14] . Complimentary DNA was synthesized from total RNA using oligo dT primer (Invitrogen) and reverse transcriptase (SuperScript III; Invitrogen). The feline CYP2D fragments were amplified by reverse transcription-polymerase chain reaction (RT-PCR) with degenerate primers using highfidelity Phusion Hot Start polymerase (Finnzymes, Espoo, Finland) and 3'-or 5'-rapid amplification of cDNA ends (3'-and 5'-RACE). The degenerate oligonucleotide primers used for PCR were based on the nucleotide sequences of CYP2D from several mammalian species (forward 5'-
, r e v e r s e 5 ' -CCAAARCGCTGYACCTCRTG-3'). The 3'-RACE and 5'-RACE procedures were conducted according to the manufacturer's instructions (3'-Full RACE and 5'-Full RACE Core Sets; Takara, Otsu, Japan). PCR products were subcloned into T-vectors (Promega, Madison, WI, U.S.A.). The nucleotide sequences of these clones were determined using an automated DNA sequencer (ABI 310 Genetic Analyzer; Applied Biosystems, Carlsbad, CA, U.S.A.) after reactions using a BigDye terminator cycle sequencing kit (Applied Biosystems). We repeated these procedures twice beginning at the RNA extraction step with two female cat livers. Sequence alignment and phylogenetic analysis were carried out using the ClustalW software (neighbor-joining method, Kimura's 2-parameter model) found on the DNA Data Bank of Japan (DDBJ) homepage. In order to examine the expression levels of feline CYP2D in the brain, heart, liver, kidney, testis and ovary, real-time RT-PCR analysis was performed with a real-time PCR detector (Chromo4; Bio-Rad, Hercules, CA, U.S.A.) using Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen), as described previously [12] . Total RNAs (brain, heart, kidney, testis and ovary) were extracted and cDNAs were synthesized, as already described for the liver. The primer pair used was 5'-ATTGGTTTATCACAGCGAGG-3' for the sense primer and 5'-CAGTGCTCCGTCTATCAGCT-3' for the antisense primer. In order to obtain standard DNA for realtime PCR, PCR fragments were amplified with a pair of primers designed outside sequence of the target PCR sequence (forward 5'-GTCCTAGGTACCTGGTGTGC-3', reverse 5'-GTTCTCATCATTGAAGCTGC-3'). After agarose gel electrophoresis, a single band of the PCR product for the standard was extracted and purified by a Wizard SV Gel and PCR Clean-Up System (Promega). The primer sets used for real-time RT-PCR were confirmed to produce a single peak in the melting curve as well as a single band by agarose gel electrophoresis. CYP2D expressions were normalized per g of total RNA used for reverse transcription.
Using degenerate RT-PCR procedures, we succeeded in obtaining cDNA of feline CYP2D with a transcription initiation codon and with both 5'-and 3'-ends (GenBank Accession No. AB547449
). An open reading frame of the feline CYP2D was 1,500 bp, and the deduced amino acid sequence was 500. The 3'-untranslated region (UTR) contained 75 nucleotides before the poly (A) tail. Heme-binding cysteine was located at position 446 (marked with plus), and the sequence of the HR2 region around the cysteine was well conserved for CYP2D (Fig. 1, underlined) . The feline sequence cloned was syntenic with human CYP2D6, based on genomic structure [4] . In the cat, no pseudogenes were contained in the CYP2D cluster, where there are two pseudogenes in humans. Thus, the feline CYP2D sequence was a presumed ortholog of CYP2D6 [4] . It is well known that humans are distinguished to extensive and poor metabolizers with respect to CYP2D6 because of its typical polymorphism [3, 15] . At some positions possibly involving at enzyme activities, some amino acids of the feline CYP2D6 are the same as those of the extensive metabolizer (human CYP2D6*1), as indicated by the conserved amino acids between feline and human CYP2Ds, including Pro at position 37 (Pro34 in humans) and Gly at 172 (Gly169 in humans), which are marked as I and III in Fig. 1 . Each mutation at Pro34 or at Gly169 is a key mutation, causing decreased enzymatic activities in human CYP2D6*10 and CYP2D6*14, respectively. However, Thr at 107 in humans was replaced with Tyr (110 in cats; marked as II in Fig. 1 ). Otherwise, Arg at 296 and Ser at 486 in the human sequence were replaced with Leu (position 299) and Ile (position 489), respectively, in the feline CYP2D6 sequence (marked as IV and V in Fig. 1 ). These three mutations are shown in human CYP2D6*17 and cause deficient activity of CYP2D6. The corresponding amino acid residues (Thr107, Arg296 and Ser486 in the human form) are also replaced with Tyr, Cys and Val in domestic dogs (positions 110, 299 and 489) [7, 11] . An in vitro study of CYP2D activities in microsomes of cat liver based on bufuralol 1'-hydroxylation, which was inhibited by quinidine, suggested relatively higher intrinsic clearance than that by the human liver on one hand [8, 13] and that the CYP2D6 activities of feline liver microsomes are comparable to those of the human liver and almost twofold higher than those of the canine liver on the other, as Fig. 1 . Comparison of CYP2D amino acid sequences from the cat, dog and human. The figures on both sides show the numbers of amino acids. Asterisks under the amino acid alignment indicate regions conserved throughout the three species. The HR2 region is underlined, and the heme-binding cysteine in this region is marked with a plus sign (+). I, II, III, IV, and V indicate corresponding amino acid residues expressed throughout the three species that are related to some important polymorphisms that are known to be associated with decreased activity in humans.
indicated by quinidine-sensitive dextromethorphan Odemethylase activity [1] . Collectively, however, it seems that the extensive metabolizer in humans, cats and dogs showed almost the same range of CYP2D activities, judging from these reported studies. Naturally, further study is needed to elucidate the structure-activity relationships of CYP2D, especially for the activity of feline CYP2D6 with artificially expressed protein.
The coding sequence for the feline CYP2D cloned in the present study shared 71.6-86.0% nucleotide similarity and 63.5-80.0% amino acid identity with other mammalian CYP2Ds (GenBank), except mouse CYP2D40 (Table 1) . Feline CYP2D showed the highest identity with CYP2D15 of the domestic dog, the only other carnivore compared, implying a relatively greater similarity with canine CYP2D. In accordance with this, phylogenetic analysis demonstrated that the feline CYP2D is in a monophyletic group with dog CYP2D15 and far from rodent CYP2Ds, but nearer to other mammalian CYP2D clusters including those of higher primates (Fig. 2) .
With the use of paired primers based on the feline CYP2D6 sequence determined above, we studied mRNA expression in various tissues by quantitative real-time RT-PCR (Fig. 3) . Among the six tissues addressed, CYP2D6 was expressed predominantly in the liver, as shown in Fig.  3 . On the other hand, much lower expression and trace expression were detected in the testis and the other tissues (brain, heart, kidney and ovary), respectively. These facts suggest that hepatic CYP2D6 is important to biotransform chemicals in cats (Fig. 3) . There was no clear preferential Fig. 2 . Phylogenetic tree of CYP2Ds. The neighbor-joining method was used based on the entire deduced amino acid sequence with feline CYP1A1 as an outgroup. Numbers on the tree represent the local bootstrap values from 1,000 replicates. CYP2D isoforms were selected according to Zanger et al. [15] expression of CYP2D by sex, although it has been reported that CYP2D activities were higher in hepatic microsomes of female cats [8] . This issue should be further studied with greater numbers of samples as well as samples from other breeds of cats before a final conclusion is drawn. In this study, feline CYP2D6 cDNA was identified, and its expression in some tissues was characterized as preliminary data. The suggestion of the possible polymorphism of CYP2D is based on the differential celecoxib metabolism in dog livers, although the involvement of another CYP molecule should be considered [5] . The possible polymorphism of feline CYP2D6 should be studied in the future, as this CYP molecule is also expected to play a major role in drug metabolism in this species [1, 8] . A functional study of feline CYP2D6 with the expressed enzyme is required to clarify the selectivity of this enzyme for drugs and other chemicals in cats because the relationship between molecular structure and metabolic activity so far remains largely unknown. As a genome project for cats is in progress, development of new clinical veterinary medicines for cats with support from molecular biology is expected in the near future. The tissues addressed were the brain (cerebrum), heart, liver, kidney cortex, testis and ovary. Results are expressed as means ± SEM per g of total RNA used for reverse transcription (n=3 for testis and ovary, n=6 for the other tissues).
